SCHEMBL22650788

SCHEMBL22650788

N#Cc1c2ccccc2c(C#N)c2c3ccc4ccc5ccccc5c4c3c3c(ccc4ccc5ccccc5c43)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.45
▸ CYP1A2 P05177 4/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ MAPT P10636 4/20 0.45
▸ HPGD P15428 3/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ HSD17B10 Q99714 6/20 0.43
▸ THRB P10828 1/20 0.43
▸ HPRT1 P00492 1/20 0.41
▸ ANPEP P15144 1/20 0.41
▸ TSHR P16473 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HIF1A Q16665 2/20 0.40
▸ ERBB2 P04626 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21791166 0.83 ALDH1A1 (0.46) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL22703043 0.80 ALDH1A1 (0.50) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL21791068 0.78 HPRT1 (0.46) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL4412391 0.77 ALDH1A1 (0.47) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL21298140 0.76 ANPEP (0.44) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL4855214 0.76 ALDH1A1 (0.68) ALDH1A1CYP1A2HPGDCYP3A4HSD17B10
SCHEMBL4063685 0.75 ALDH1A1 (0.52) ALDH1A1CYP1A2KDM4EMAPTHPGD
SCHEMBL535472 0.74 HSD17B10 (0.72) ALDH1A1CYP1A2HPGDCYP3A4HSD17B10
SCHEMBL29487823 0.74 HSD17B10 (0.72) ALDH1A1CYP1A2HPGDCYP3A4HSD17B10
SCHEMBL29613365 0.74 HSD17B10 (0.72) ALDH1A1CYP1A2HPGDCYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes University of Wyoming-Office of Research & Economic Development (US) 2022-05-03 — — US disclosed
US-20200354294-A1 SYNTHESES, CHARACTERIZATIONS, AND APPLICATIONS OF HELI-ACENES UNIVERSITY OF WYOMING (US) 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes HRH1, EHD1, CRY1 ALDH1A1 1022/4885CYP1A2 250/4885KDM4E 3879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback